Point72 Asset Management
SANA icon

Point72 Asset Management’s Sana Biotechnology SANA Stock Holding History

Point72 Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-363,618
Closed -$593K – 2480
2024
Q4 		$593K Buy
+363,618
New +$1.08M ﹤0.01% 1624

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's SANA Position: Q1 2025 in Review

Point72 Asset Management sold out of Sana Biotechnology (SANA) in Q1 2025, closing a stake of 363,618 shares — an estimated $593K sold.

Point72 Asset Management first reported a position in SANA in Q4 2024 and held it in 1 quarter. The position peaked at $593K in Q4 2024. 161 funds tracked by Wall St. Rank hold SANA as of Q1 2025.

  • Point72 Asset Management reported no remaining Sana Biotechnology position as of Q1 2025 after selling out during the quarter.
  • Point72 Asset Management sold 363,618 Sana Biotechnology shares in Q1 2025, an estimated $593K.
  • Point72 Asset Management first reported a position in Sana Biotechnology in Q4 2024 and held it in 1 quarter.
  • Point72 Asset Management's Sana Biotechnology position peaked at $593K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2025.

Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.